Reading the tape
NASDAQ: LFST
LifeStance Health Group, Inc.
Healthcare · Medical - Care Facilities
Market Cap
$2.83B
52w High
$8.09
52w Low
$3.74
P/E
291.62
Volume
26.19K
Outstanding Shares
387.83M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 9.82%Revenue (TTM): 13.85%FCF (TTM): 70.55%P/S: 21st pct
What changed
The stock rose 9.82% over the last year. Revenue grew 13.85% over the trailing twelve months. Operating margin moved from -2.53% to 1.72%. Free cash flow grew 70.55% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 1.72%. A decisive move in revenue — currently up 13.85% — would be the clearest signal to resolve the ambiguity.
Company profile
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services.
CEODavid Patrick Bourdon
SectorHealthcare
IndustryMedical - Care Facilities
Employees7,535
IPO dateJun 10, 2021
Valuation
Forward P/E—
EV/EBITDA33.80
Enterprise value$2.66B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth17.43%
Gross margin30.45%▼11.31%vs FY2024
Operating margin1.72%▲171.42%vs FY2024
ROE0.64%▲116.00%vs FY2024
Analyst consensus
RatingBuy
Target price$9.30▲27.40%
10
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
Q2 FY26 · EPS est $0.01 · Revenue est $387.46M
View